CLOs on the Move

MSI

www.methylationsciences.com

 
MSI Methylation Sciences Inc. (“MSI”) is a clinical-stage pharmaceutical company focused on developing new products based on molecules which have clinical proof of concept but which have yet to be exploited in the major pharmaceutical markets. MSI`s focus is in the CNS space where clinical proof of concept is key to reducing the drug development risk. Our lead product candidate, Strada™, is based upon Ademetionine, a naturally occurring molecule produced throughout the body, where it plays a vital role in the one-carbon cycle. Our disease indication is Major Depressive Disorder (MDD).
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Similar Companies

Equipment Placement Svc

Equipment Placement Svc is a Streetman, TX-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Iroko Pharmaceuticals

Iroko Pharmaceuticals is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Philadelphia, PA.

Hitachi Chemical Diagnostics Inc

Hitachi Chemical Diagnostics Inc is a Mountain View, CA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

APAC Pharmaceutical

APAC Pharmaceutical is a Columbia, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Upward Health

Prior to Upward Health, Ward served as the Senior Vice President of Analytics at CareSource, a large health plan based in Ohio with multiple product lines in several states. Before CareSource, Ward held data and analytics leadership roles at a wide range of healthcare companies including Navvis, Corizon Health, naviHealth, and Centene. Ward brings to Upward Health a deep experience building prediction models, implementing business intelligence solutions, and driving process improvement through technology innovation.